GRIA-2 -EP387

Neuroendocrine Tumor stained with Anti GRIA-2

GRIA-2 -EP387

Glutamate Receptor2(GRIA2) is a ligand gated ion channel that uses l-glutamate for excitatory synaptic transmission expressed in  the central nervous system. A recent gene expression profiling study reported> 100 fold GRIA2 induction in solitary fibrous tumors compared with control tissues. Immunohistochemistry studies demonstrated GRIA-2 positivity in the majority of solitary fibrous tumors(64-86%).Its diagnostic performance yields 64% sensitivity , 92% specificity , with 41% and 97% positive and negative predictive value,respectively for the differential diagnosis of solitary fibrous tumors versus other mesenchymal soft tissue tumors.GRIA-2 may be useful marker to identify STST-6 negative Solitary fibrous tumors.

  • Description
  • Specifications
  • Ordering Information

Glutamate Receptor2(GRIA2) is a ligand gated ion channel that uses l-glutamate for excitatory synaptic transmission expressed in  the central nervous system. A recent gene expression profiling study reported> 100 fold GRIA2 induction in solitary fibrous tumors compared with control tissues. Immunohistochemistry studies demonstrated GRIA-2 positivity in the majority of solitary fibrous tumors(64-86%).Its diagnostic performance yields 64% sensitivity , 92% specificity , with 41% and 97% positive and negative predictive value,respectively for the differential diagnosis of solitary fibrous tumors versus other mesenchymal soft tissue tumors.GRIA-2 may be useful marker to identify STST-6 negative Solitary fibrous tumors.

  • Source
    Rabbit Monoclonal
  • Clone
    EP387
  • Class
    IVD
  • Isotype
    Rabbit IgG1
  • Tested Reactivity
    Human, FFPE
  • Localization
    Cytoplasmic and Membrane
  • Positive Control
    Brain and Neuroendocrine Tumors
  • Catalog
    Pack Size
  • PR281-3ml
    3ml(RTU)
  • PR281-6ml
    6ml(RTU)
  • CR281 - 1ml
    1ml ( Conc. )
  • CR281 - 0.5ml
    0.5ml ( Conc. )
  • CR281 - 0.1ml
    0.1ml ( Conc. )